Performance of two multiplex flow cytometric assays for antibody detection in Egyptian patients

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Performance of two multiplex flow cytometric assays for antibody detection in Egyptian patients
 
Creator Ahmed, Alshymaa A. El Shahaway, Alia A. Kadry, Heba M. Said, Nora M.
 
Subject immunology;methods;autoantibodies; autoantibodies; anti-double-stranded DNA; anti-neutrophil cytoplasmic antibodies; multiplex; performance
Description Background: Autoantibodies are vital biomarkers for the diagnosis, assessment and prognostic determination of various autoimmune disorders.Objective: This study aimed to evaluate the performance of the two AtheNA Multi-Lyte® systems for the detection of various autoantibodies.Methods: A total of 105 systemic lupus erythematosus patients, 35 patients with other autoimmune diseases (diseased controls), and 30 healthy volunteers (healthy controls) at Zagazig University Hospitals, Zagazig city, Al Sharqia governorate were tested for anti-double-stranded DNA (anti-dsDNA) antibodies using indirect immunofluorescence (IIF) and the AtheNA Multi-Lyte® anti-nuclear antibodies-II system between May 2020 and April 2022. Seventy-five patients with clinically suspected autoimmune vasculitis (AIV) and 25 healthy volunteers were also tested for anti-myeloperoxidase and anti-proteinase 3 antibodies using IIF, the AtheNA Multi-Lyte® AIV system, and enzyme-linked immunosorbent assay (ELISA).Results: The AtheNA anti-dsDNA test (98.5%) was more specific than IIF (96.9%) for diagnosing systemic lupus erythematosus, but both tests had the same sensitivity (38.1%). Combining both methods increased sensitivity to 47.6%, while increasing the cut-off of the AtheNA anti-dsDNA test to 134 international units/mL increased specificity to 100%. The AtheNA Multi-Lyte AIV system exhibited substantial agreement with IIF regarding anti-myeloperoxidase testing (κ = 0.65) and almost perfect agreement with ELISA (κ = 0.85). The AtheNA Multi-Lyte® AIV system exhibited perfect agreement with IIF (κ = 1) and substantial agreement with ELISA for anti-proteinase 3 testing (κ = 0.63).Conclusion: AtheNA Multi-Lyte® systems appear to be reliable for anti-dsDNA, anti-myeloperoxidase, and anti-proteinase 3 screening and may be an optimal choice for monitoring anti-dsDNA levels.What this study adds: It is necessary to evaluate various autoantibodies detection assays to increase both sensitivity and specificity of autoimmune diseases diagnostic approaches. AtheNA Multi-Lyte® systems appear to be reliable for anti-dsDNA, anti-myeloperoxidase, and anti-proteinase 3 screening and may be an optimal choice for monitoring anti-dsDNA levels. 
 
Publisher AOSIS
 
Contributor none
Date 2023-05-18
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — analysis
Format text/html application/epub+zip text/xml application/pdf application/pdf
Identifier 10.4102/ajlm.v12i1.2099
 
Source African Journal of Laboratory Medicine; Vol 12, No 1 (2023); 7 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/2099/2659 https://ajlmonline.org/index.php/ajlm/article/view/2099/2660 https://ajlmonline.org/index.php/ajlm/article/view/2099/2661 https://ajlmonline.org/index.php/ajlm/article/view/2099/2663 https://ajlmonline.org/index.php/ajlm/article/view/2099/2662
 
Coverage - - adult; both gender; egyptian
Rights Copyright (c) 2023 Alshymaa A. Ahmed, Alia A. El Shahawy, Heba M. Kadry, Nora M. Said https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT